Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Amgen’s Blincyto gets expanded indication for B-cell ALL in Europe

pharmaceutical-technologyJanuary 24, 2019

Tag: Amgen , BLINCYTO , ALL , CD19

PharmaSources Customer Service